Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01985997 · ClinicalTrials.gov registry record
Postmarketing Safety Study of Q/LAIV in Subjects 2 Through 49 Years of Age
A clinical trial of Observation Safety, sponsored by MedImmune.
- Completed
- Registry status
- 95,000
- Enrollment target
- 1
- Study location
NCT01985997 is a study of Observation Safety that has completed, run by MedImmune. The registered enrollment target is 95,000 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01985997, a study of Observation Safety, has completed, sponsored by MedImmune.
- COMPLETED
- Registry status
- 95,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an observational post-marketing study conducted in children and adults immunized with Q/LAIV as part of routine clinical practice at Kaiser Permanente Northern California (NCKP) sites.
Conditions Studied
Study Locations (1)
California
- Research Site - Oakland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95,000 participants |
| Start Date | 2014-01 |
| Est. Completion | 2014-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01985997
The ClinicalTrials.gov registry entry for NCT01985997 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 95,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedImmune, which has 210 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Observation Safety appearing as the primary indexed condition, and to 0 interventions.
NCT01985997 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01985997 about?
NCT01985997 is a clinical study titled "Postmarketing Safety Study of Q/LAIV in Subjects 2 Through 49 Years of Age". This is an observational post-marketing study conducted in children and adults immunized with Q/LAIV as part of routine clinical practice at Kaiser Permanente Northern California (NCKP) sites.
What is the current status of trial NCT01985997?
This trial is currently completed. The enrollment target is 95,000 participants. The study started on 2014-01. Estimated completion is 2014-07.
What conditions does trial NCT01985997 study?
This clinical trial studies the following conditions: Observation Safety.
Who is sponsoring clinical trial NCT01985997?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01985997 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.